 | • レポートコード：MRC2012A10241 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、旅行者下痢治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。旅行者下痢治療薬の種類別市場規模（予防接種、非抗生剤、抗生物質、反運動性剤、その他）、用途別市場規模（大人旅行者下痢、子供旅行者下痢）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Salix Pharmaceuticals、Livzon、Otsuka Pharma、P&G、PaxVax、Johnson & Johnson、Shanghai United Cell、Valneva、Immuron、 ・地域別グローバル市場分析 2015年-2020年 ・旅行者下痢治療薬の北米市場（アメリカ、カナダ、メキシコ） ・旅行者下痢治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・旅行者下痢治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・旅行者下痢治療薬の南米市場（ブラジル、アルゼンチン） ・旅行者下痢治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：予防接種、非抗生剤、抗生物質、反運動性剤、その他 ・用途別分析：大人旅行者下痢、子供旅行者下痢 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Traveler’s Diarrhea Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Traveler’s Diarrhea Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 973.6 million by 2025, from USD 748.5 million in 2019.
Market segmentation
Traveler’s Diarrhea Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Traveler’s Diarrhea Therapeutics market has been segmented into
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
By Application, Traveler’s Diarrhea Therapeutics has been segmented into:
Adult Traveler’s Diarrhea
Children Traveler’s Diarrhea
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Traveler’s Diarrhea Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Traveler’s Diarrhea Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Traveler’s Diarrhea Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Traveler’s Diarrhea Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Traveler’s Diarrhea Therapeutics Market Share Analysis
Traveler’s Diarrhea Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Traveler’s Diarrhea Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Traveler’s Diarrhea Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Traveler’s Diarrhea Therapeutics are:
Salix Pharmaceuticals
Livzon
Otsuka Pharma
P&G
PaxVax
Johnson & Johnson
Shanghai United Cell
Valneva
Immuron
Among other players domestic and global, Traveler’s Diarrhea Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Traveler’s Diarrhea Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Traveler’s Diarrhea Therapeutics, with price, sales, revenue and global market share of Traveler’s Diarrhea Therapeutics in 2018 and 2019.
Chapter 3, the Traveler’s Diarrhea Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Traveler’s Diarrhea Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Traveler’s Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Traveler’s Diarrhea Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Traveler’s Diarrhea Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Traveler’s Diarrhea Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Traveler’s Diarrhea Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult Traveler’s Diarrhea
1.3.3 Children Traveler’s Diarrhea
1.4 Overview of Global Traveler’s Diarrhea Therapeutics Market
1.4.1 Global Traveler’s Diarrhea Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Salix Pharmaceuticals
2.1.1 Salix Pharmaceuticals Details
2.1.2 Salix Pharmaceuticals Major Business
2.1.3 Salix Pharmaceuticals SWOT Analysis
2.1.4 Salix Pharmaceuticals Product and Services
2.1.5 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Livzon
2.2.1 Livzon Details
2.2.2 Livzon Major Business
2.2.3 Livzon SWOT Analysis
2.2.4 Livzon Product and Services
2.2.5 Livzon Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Otsuka Pharma
2.3.1 Otsuka Pharma Details
2.3.2 Otsuka Pharma Major Business
2.3.3 Otsuka Pharma SWOT Analysis
2.3.4 Otsuka Pharma Product and Services
2.3.5 Otsuka Pharma Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 P&G
2.4.1 P&G Details
2.4.2 P&G Major Business
2.4.3 P&G SWOT Analysis
2.4.4 P&G Product and Services
2.4.5 P&G Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 PaxVax
2.5.1 PaxVax Details
2.5.2 PaxVax Major Business
2.5.3 PaxVax SWOT Analysis
2.5.4 PaxVax Product and Services
2.5.5 PaxVax Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Product and Services
2.7.4 Shanghai United Cell Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Valneva
2.8.1 Valneva Details
2.8.2 Valneva Major Business
2.8.3 Valneva Product and Services
2.8.4 Valneva Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Immuron
2.9.1 Immuron Details
2.9.2 Immuron Major Business
2.9.3 Immuron Product and Services
2.9.4 Immuron Traveler’s Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Traveler’s Diarrhea Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Traveler’s Diarrhea Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Traveler’s Diarrhea Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Traveler’s Diarrhea Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Traveler’s Diarrhea Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Traveler’s Diarrhea Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Traveler’s Diarrhea Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Traveler’s Diarrhea Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Traveler’s Diarrhea Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Traveler’s Diarrhea Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Traveler’s Diarrhea Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Traveler’s Diarrhea Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Traveler’s Diarrhea Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Traveler’s Diarrhea Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Traveler’s Diarrhea Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Traveler’s Diarrhea Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Traveler’s Diarrhea Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Traveler’s Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Traveler’s Diarrhea Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Traveler’s Diarrhea Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Traveler’s Diarrhea Therapeutics Price by Type (2015-2020)
11 Global Traveler’s Diarrhea Therapeutics Market Segment by Application
11.1 Global Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Traveler’s Diarrhea Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Traveler’s Diarrhea Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Traveler’s Diarrhea Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Traveler’s Diarrhea Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Traveler’s Diarrhea Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Traveler’s Diarrhea Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Traveler’s Diarrhea Therapeutics Market Forecast (2021-2025)
12.2.4 South America Traveler’s Diarrhea Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Traveler’s Diarrhea Therapeutics Market Forecast (2021-2025)
12.3 Traveler’s Diarrhea Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Traveler’s Diarrhea Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Traveler’s Diarrhea Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Traveler’s Diarrhea Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Traveler’s Diarrhea Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Traveler’s Diarrhea Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Traveler's Diarrhea Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Traveler's Diarrhea Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Traveler's Diarrhea Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Traveler's Diarrhea Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Major Business
Table 10. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 11. Salix Pharmaceuticals SWOT Analysis
Table 12. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product and Services
Table 13. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Livzon Basic Information, Manufacturing Base and Competitors
Table 15. Livzon Traveler's Diarrhea Therapeutics Major Business
Table 16. Livzon Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 17. Livzon SWOT Analysis
Table 18. Livzon Traveler's Diarrhea Therapeutics Product and Services
Table 19. Livzon Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Otsuka Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Otsuka Pharma Traveler's Diarrhea Therapeutics Major Business
Table 22. Otsuka Pharma Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 23. Otsuka Pharma SWOT Analysis
Table 24. Otsuka Pharma Traveler's Diarrhea Therapeutics Product and Services
Table 25. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. P&G Basic Information, Manufacturing Base and Competitors
Table 27. P&G Traveler's Diarrhea Therapeutics Major Business
Table 28. P&G Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 29. P&G SWOT Analysis
Table 30. P&G Traveler's Diarrhea Therapeutics Product and Services
Table 31. P&G Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. PaxVax Basic Information, Manufacturing Base and Competitors
Table 33. PaxVax Traveler's Diarrhea Therapeutics Major Business
Table 34. PaxVax Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 35. PaxVax SWOT Analysis
Table 36. PaxVax Traveler's Diarrhea Therapeutics Product and Services
Table 37. PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Traveler's Diarrhea Therapeutics Major Business
Table 40. Johnson & Johnson Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 41. Johnson & Johnson SWOT Analysis
Table 42. Johnson & Johnson Traveler's Diarrhea Therapeutics Product and Services
Table 43. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 45. Shanghai United Cell Traveler's Diarrhea Therapeutics Major Business
Table 46. Shanghai United Cell Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 47. Shanghai United Cell SWOT Analysis
Table 48. Shanghai United Cell Traveler's Diarrhea Therapeutics Product and Services
Table 49. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Valneva Basic Information, Manufacturing Base and Competitors
Table 51. Valneva Traveler's Diarrhea Therapeutics Major Business
Table 52. Valneva Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 53. Valneva SWOT Analysis
Table 54. Valneva Traveler's Diarrhea Therapeutics Product and Services
Table 55. Valneva Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Immuron Basic Information, Manufacturing Base and Competitors
Table 57. Immuron Traveler's Diarrhea Therapeutics Major Business
Table 58. Immuron Traveler's Diarrhea Therapeutics Total Revenue (USD Million) (2018-2019)
Table 59. Immuron SWOT Analysis
Table 60. Immuron Traveler's Diarrhea Therapeutics Product and Services
Table 61. Immuron Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Traveler's Diarrhea Therapeutics Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Traveler's Diarrhea Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Traveler's Diarrhea Therapeutics Sales by Regions (2015-2020) (K Units)
Table 65. Global Traveler's Diarrhea Therapeutics Sales Market Share by Regions (2015-2020)
Table 66. Global Traveler's Diarrhea Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020) (K Units)
Table 68. North America Traveler's Diarrhea Therapeutics Sales Market Share by Countries (2015-2020)
Table 69. North America Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020) (K Units)
Table 72. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Countries (2015-2020)
Table 73. Europe Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020) (K Units)
Table 78. South America Traveler's Diarrhea Therapeutics Sales Market Share by Countries (2015-2020)
Table 79. South America Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020)
Table 85. Global Traveler's Diarrhea Therapeutics Sales by Type (2015-2020) (K Units)
Table 86. Global Traveler's Diarrhea Therapeutics Sales Share by Type (2015-2020)
Table 87. Global Traveler's Diarrhea Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 88. Global Traveler's Diarrhea Therapeutics Revenue Share by Type (2015-2020)
Table 89. Global Traveler's Diarrhea Therapeutics Sales by Application (2015-2020) (K Units)
Table 90. Global Traveler's Diarrhea Therapeutics Sales Share by Application (2015-2020)
Table 91. Global Traveler's Diarrhea Therapeutics Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Traveler's Diarrhea Therapeutics Market Share Forecast by Regions (2021-2025)
Table 93. Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Traveler's Diarrhea Therapeutics Market Share Forecast by Type (2021-2025)
Table 95. Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2021-2025)
Table 96. Global Traveler's Diarrhea Therapeutics Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Traveler's Diarrhea Therapeutics Picture
Figure 2. Global Sales Market Share of Traveler's Diarrhea Therapeutics by Type in 2019
Figure 3. Immunization Picture
Figure 4. Non-antibiotic Agents Picture
Figure 5. Antibiotics Picture
Figure 6. Anti-Motility Agents Picture
Figure 7. Others Picture
Figure 8. Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 9. Adult Traveler's Diarrhea Picture
Figure 10. Children Traveler's Diarrhea Picture
Figure 11. Global Traveler's Diarrhea Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Traveler's Diarrhea Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturer in 2019
Figure 32. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Traveler's Diarrhea Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Traveler's Diarrhea Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 39. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Regions in 2018
Figure 40. North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
Figure 41. Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. South America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. North America Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Traveler's Diarrhea Therapeutics Sales Market Share by Countries (2015-2020)
Figure 47. North America Traveler's Diarrhea Therapeutics Sales Market Share by Countries in 2018
Figure 48. North America Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Traveler's Diarrhea Therapeutics Revenue Market Share by Countries in 2018
Figure 50. United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Germany Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue Market Share by Regions 2019
Figure 64. China Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Traveler's Diarrhea Therapeutics Sales Market Share by Countries in 2019
Figure 71. South America Traveler's Diarrhea Therapeutics Revenue Market Share by Countries in 2019
Figure 72. Brazil Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Traveler's Diarrhea Therapeutics Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Traveler's Diarrhea Therapeutics Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Traveler's Diarrhea Therapeutics Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Traveler's Diarrhea Therapeutics Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Traveler's Diarrhea Therapeutics Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
カルチノイド症候群下痢治療の世界市場（～2026年） Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syn…- 豚流行性下痢ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Porcine Epidemic Diarrhea Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Porcine Ep…
- ホジキンリンパ腫治療薬の世界市場（～2026年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- スマートキャリーオンバッグの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Smart Carry-on Bags market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1040.5 million by 2025, from USD 688.2 million in 2019. The Smart Carry-on B…
- ヒラタケ属エリンギの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pleurotus Eryngii market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pleurotus Eryngii market re…